Ralph Charlton

Ralph Charlton

Chief Tech/Sci/R&D Officer at SPRUCE BIOSCIENCES, INC.

Net worth: 43 523 $ as of 31/03/2024

54 year
Health Technology
Consumer Services

Profile

Ralph William Charlton is currently the Chief Medical Officer at Spruce Biosciences, Inc. Prior to this, he worked as the Executive Medical Director at Allergan, Inc. from 2018 to 2019, Senior Medical Director-Clinical Development at Ascendis Pharma, Inc. from 2019 to 2020, and Vice President-Clinical Development at 89bio, Inc. from 2020 to 2022.
Charlton earned a doctorate degree from the University of Southern California.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
25/03/2024 55,373 ( 0.13% ) 43 523 $ 31/03/2024

Ralph Charlton active positions

CompaniesPositionStart
SPRUCE BIOSCIENCES, INC. Chief Tech/Sci/R&D Officer 14/03/2022
All active positions of Ralph Charlton

Former positions of Ralph Charlton

CompaniesPositionEnd
89BIO, INC. Chief Tech/Sci/R&D Officer 01/02/2022
Ascendis Pharma, Inc. Chief Tech/Sci/R&D Officer 01/11/2020
ALLERGAN, INC. Chief Tech/Sci/R&D Officer 01/05/2019
See the detail of Ralph Charlton's experience

Training of Ralph Charlton

University of Southern California Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ralph Charlton's experience

Connections

24

1st degree connections

5

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
SPRUCE BIOSCIENCES, INC.

Health Technology

89BIO, INC.

Health Technology

Private companies2

Health Technology

Ascendis Pharma, Inc.

See company connections
  1. Stock Market
  2. Insiders
  3. Ralph Charlton